This presentation will include information on the current state of gene therapy in neuromuscular disease. It will include successes and failures using spinal muscular atrophy, Duchenne muscular dystrophy and XL-myotubular myopathy as examples.
Level of instruction: intermediate
![overlay-bottom[1]](https://ambrygen.com/wp-content/uploads/2026/02/overlay-bottom1.svg)